1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of cancer across the world
5.1.1.2. Growing adoption of immunotherapy over other treatments
5.1.1.3. Developments of bioinformatics tools and resources for cancer immunotherapy study
5.1.2. Restraints
5.1.2.1. Possibilities of adverse effects of the available therapies
5.1.3. Opportunities
5.1.3.1. Recent developments in immunotherapy technologies
5.1.3.2. Significant investment and funding for immunotherapy research
5.1.4. Challenges
5.1.4.1. High cost of therapy and unpredictable effectiveness of immuno-oncology agents
5.2. Cumulative Impact of COVID-19

6. Cancer Immunotherapy Drugs Market, by Type
6.1. Introduction
6.2. Cancer Vaccines
6.3. Checkpoint Inhibitors
6.4. Immunomodulators
6.5. Monoclonal Antibodies

7. Cancer Immunotherapy Drugs Market, by End-user
7.1. Introduction
7.2. Hospitals & Clinics

8. Cancer Immunotherapy Drugs Market, by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Colorectal Cancer
8.4. Head and Neck Cancer
8.5. Lung Cancer
8.6. Melanoma
8.7. Prostate Cancer

9. Americas Cancer Immunotherapy Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cancer Immunotherapy Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Cancer Immunotherapy Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Amgen Inc.
13.2. AstraZeneca plc
13.3. Atara Biotherapeutics, Inc.
13.4. Bayer AG
13.5. Bluebird bio, Inc.
13.6. Bristol-Myers Squibb
13.7. Celldex Therapeutics
13.8. Cellectis
13.9. ELI Lilly and Company
13.10. F. Hoffmann-La Roche Ltd
13.11. Gilead Sciences, Inc.
13.12. GlaxoSmithKline plc
13.13. Incyte Corporation
13.14. Janssen Global Services, LLC
13.15. Juno Therapeutics
13.16. Merck & Co., Inc.
13.17. NewLink Genetics Corporation
13.18. Novartis AG
13.19. Pfizer Inc.
13.20. Ziopharm Oncology, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY TYPE, 2027
FIGURE 6. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CANCER VACCINES, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CANCER VACCINES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CHECKPOINT INHIBITORS, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY IMMUNOMODULATORS, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2027 (USD BILLION)
FIGURE 13. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 15. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY END-USER, 2020 VS 2027 (USD BILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY END-USER, 2027
FIGURE 17. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 20. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY APPLICATION, 2027
FIGURE 22. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY BREAST CANCER, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HEAD AND NECK CANCER, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY LUNG CANCER, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MELANOMA, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MELANOMA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY PROSTATE CANCER, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 34. AMERICAS CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. ARGENTINA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. BRAZIL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. CANADA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. MEXICO CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. UNITED STATES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. ASIA-PACIFIC CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. AUSTRALIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. CHINA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. INDIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. INDONESIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. JAPAN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. MALAYSIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. PHILIPPINES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. SINGAPORE CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. SOUTH KOREA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. TAIWAN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. THAILAND CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. FRANCE CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. GERMANY CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. ITALY CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. NETHERLANDS CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. QATAR CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. RUSSIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. SAUDI ARABIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. SOUTH AFRICA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. SPAIN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. UNITED ARAB EMIRATES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. UNITED KINGDOM CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. AMERICAS CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 18. ARGENTINA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 19. BRAZIL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. CANADA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. MEXICO CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. UNITED STATES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. AUSTRALIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. CHINA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. INDIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. INDONESIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. JAPAN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. MALAYSIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. PHILIPPINES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. SINGAPORE CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. SOUTH KOREA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. TAIWAN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. THAILAND CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. FRANCE CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. GERMANY CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. ITALY CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. NETHERLANDS CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. QATAR CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. RUSSIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. SAUDI ARABIA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. SOUTH AFRICA CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. SPAIN CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. UNITED ARAB EMIRATES CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. UNITED KINGDOM CANCER IMMUNOTHERAPY DRUGS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: SCORES
TABLE 48. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: BUSINESS STRATEGY
TABLE 49. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: PRODUCT SATISFACTION
TABLE 50. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: RANKING
TABLE 51. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 52. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Amgen Inc.
AstraZeneca plc
Atara Biotherapeutics, Inc.
Bayer AG
Bluebird bio, Inc.
Bristol-Myers Squibb
Celldex Therapeutics
Cellectis
ELI Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences, Inc.
GlaxoSmithKline plc
Incyte Corporation
Janssen Global Services, LLC
Juno Therapeutics
Merck & Co., Inc.
NewLink Genetics Corporation
Novartis AG
Pfizer Inc.
Ziopharm Oncology, Inc.